tiprankstipranks
Oncolytics Biotech (ONCY)
NASDAQ:ONCY
US Market
ONCY
Oncolytics Biotech
RESEARCH TOOLSreports
Want to see ONCY full AI Analyst Report?

Oncolytics Biotech (ONCY) Financial Statements

1,549 Followers

Oncolytics Biotech Financial Overview

Oncolytics Biotech's market cap is currently $119.61M. The company's EPS TTM is $-0.0073335; its P/E ratio is -2.91; Oncolytics Biotech is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ 0.00C$ -298.59KC$ -301.11KC$ -360.57K
Operating IncomeC$ -28.73MC$ -34.98MC$ -25.04MC$ -20.68MC$ -20.93M
EBITDAC$ -28.73MC$ -34.88MC$ -20.19MC$ -18.71MC$ -20.58M
Net IncomeC$ -28.76MC$ -31.71MC$ -20.56MC$ -19.08MC$ -20.98M
Balance Sheet
Cash & Short-Term InvestmentsC$ 5.20MC$ 15.94MC$ 34.91MC$ 32.14MC$ 41.26M
Total AssetsC$ 7.58MC$ 20.19MC$ 38.82MC$ 37.33MC$ 45.88M
Total DebtC$ 563.00KC$ 1.06MC$ 423.00KC$ 373.00KC$ 655.00K
Net DebtC$ -4.64MC$ -14.88MC$ -34.49MC$ -11.29MC$ -40.61M
Total LiabilitiesC$ 11.38MC$ 14.20MC$ 11.26MC$ 10.83MC$ 9.78M
Stockholders' EquityC$ -3.80MC$ 5.98MC$ 27.56MC$ 26.50MC$ 36.10M
Cash Flow
Free Cash FlowC$ -20.11MC$ -27.20MC$ -28.46MC$ -23.41MC$ -22.72M
Operating Cash FlowC$ -20.11MC$ -26.97MC$ -28.45MC$ -23.36MC$ -22.43M
Investing Cash FlowC$ -6.00KC$ -239.00KC$ 20.22MC$ -20.40MC$ -285.95K
Financing Cash FlowC$ 14.12MC$ 6.64MC$ 31.99MC$ 12.21MC$ 33.02M
Currency in CAD

Oncolytics Biotech Earnings and Revenue History

Income Statement >

Oncolytics Biotech Debt to Assets

Balance Sheet >

Oncolytics Biotech Cash Flow

Cash Flow >

Oncolytics Biotech Forecast EPS vs Actual EPS

Earnings >